Inter Parfums, Inc. (IPAR): Price and Financial Metrics
Inter Parfums, Inc. (IPAR)
Today's Latest Price: $41.30 USD
Updated Oct 23 4:00pm
Add IPAR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 65 in Fashion & Luxury
See all "A" rated Strong Buy stocks
IPAR Stock Summary
- Of note is the ratio of Inter Parfums Inc's sales and general administrative expense to its total operating expenses; 87.82% of US stocks have a lower such ratio.
- With a year-over-year growth in debt of -24.4%, Inter Parfums Inc's debt growth rate surpasses merely 11.66% of about US stocks.
- As for revenue growth, note that IPAR's revenue has grown -19.4% over the past 12 months; that beats the revenue growth of just 15.87% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Inter Parfums Inc, a group of peers worth examining would be GRC, RELL, WEYS, SAMG, and UTI.
- Visit IPAR's SEC page to see the company's official filings. To visit the company's web site, go to www.interparfumsinc.com.
IPAR Stock Price Chart Interactive Chart >
IPAR Price/Volume Stats
| Current price | $41.30 | 52-week high | $81.40 |
| Prev. close | $41.76 | 52-week low | $34.20 |
| Day low | $41.22 | Volume | 92,700 |
| Day high | $43.56 | Avg. volume | 133,262 |
| 50-day MA | $41.49 | Dividend yield | N/A |
| 200-day MA | $48.62 | Market Cap | 1.30B |
Inter Parfums, Inc. (IPAR) Company Bio
Inter Parfums manufactures, markets, and distributes a range of fragrances and fragrance related products worldwide. The company was founded in 1985 and is based in New York, New York.
IPAR Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $41.30 | $14.31 | -65% |
We started the process of determining a valid price forecast for Inter Parfums Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Inter Parfums Inc ranked in the 23th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 65.17%. In terms of the factors that were most noteworthy in this DCF analysis for IPAR, they are:
- The company has produced more trailing twelve month cash flow than merely 23.69% of its sector Consumer Defensive.
- The business' balance sheet suggests that 4% of the company's capital is sourced from debt; this is greater than merely 13.09% of the free cash flow producing stocks we're observing.
- IPAR's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 45.64% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -66% |
| 1% | -66% |
| 2% | -65% |
| 3% | -65% |
| 4% | -65% |
| 5% | -64% |
UTI, AGFS, EPC, HRL, and SMPL can be thought of as valuation peers to IPAR, in the sense that they are in the Consumer Defensive sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...